Users report that individual response varies and that slow titration matters as much as the molecule chosen. Tirzepatide is most often named as the compound with the lowest overall side-effect burden at full doses, followed by retatrutide then semaglutide; cagrilintide is viewed as harsher while eloralintide appears tolerable only at low doses. Low-dose retatrutide or cagrilintide can still deliver useful weight loss with fewer complaints. Everyone stresses that personal trial-and-error is required because anecdotes show people tolerating one but not another.
What this discussion establishesRanking of side-effect severity at maximum doses and whether low-dose retatrutide can outperform higher-dose tirzepatide for some users
Still openHow any given individual will respond until they actually try each compound
Nothing here is advice.
How do the side effects stack up across the current options like semaglutide, tirzepatide, retatrutide, eloralintide, cagrilintide and the newer ones? What factors go into choosing one over another when balancing unwanted effects against how well they work?
You really cannot predict it without trying each one. Nausea shows up with every option, yet personal accounts indicate some users feel sick on sema but not on tirz, while others experience the opposite.
If the goal is keeping side effects manageable, the speed of dose increases matters at least as much as which drug is picked. Tirzepatide would be my first guess for the best balance of results and tolerability, though nothing is guaranteed for any single person. Some compounding services use cautious schedules that begin at low weekly amounts and only step up after checking tolerance over several weeks. Taking time with the increases seems to give the best odds of staying comfortable. Any effective dose of these drugs will produce noticeable changes beyond just the scale moving.
Nausea risk looks higher with sema. Retatrutide can push heart rate up. Plenty of things can go wrong, so caution is warranted.
I have everything the original poster listed except eloralintide. So far I am only using tirzepatide because it is working well enough. I also have retatrutide on hand, including some smaller-dose kits to test, plus semaglutide and cagrilintide in case I want stronger appetite suppression later. The plan is to keep tirzepatide going and possibly add split retatrutide doses when the time comes, treating the others as occasional extras. Still, as already noted, you cannot know how any of them will feel until you actually use them.
Tirzepatide appears to have the lowest overall side-effect rates, then retatrutide, then semaglutide when all are taken to their highest doses. Cagrilintide produces more problems; eloralintide seems milder at small amounts but gets worse quickly as the dose rises. How much weight still needs to come off also matters, since low-dose retatrutide or cagrilintide can give solid results with fewer complaints. It is possible a modest retatrutide amount could end up easier to handle than a larger tirzepatide dose that achieves the same loss.
If you have tried it, this topic is still open. Sign in to reply — it takes a minute.